FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3248611000001104: Terbutaline 250micrograms/actuation inhaler with spacer 400 dose (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22175901000001112 Terbutaline 250micrograms/actuation inhaler with spacer 400 dose (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38188301000001116 Terbutaline 250micrograms/dose inhaler with spacer 400 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Is pack of Terbutaline sulfate 250micrograms spacer inhaler false Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Has active ingredient Terbutaline sulfate false Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Has manufactured dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Has VMP Terbutaline sulfate 250micrograms spacer inhaler false Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Has specific active ingredient Terbutaline sulfate true Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Has VMP Terbutaline 250micrograms/dose inhaler with spacer false Inferred relationship Existential restriction modifier
Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Has VMP Terbutaline 250micrograms/dose inhaler with spacer true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Bricanyl 250micrograms/actuation spacer inhaler (AstraZeneca) 400 dose Is a True Terbutaline 250micrograms/actuation inhaler with spacer 400 dose Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start